Soligenix COVID-19 Vaccine Demonstrates Efficacy in Non-Human Primates Industry News September 28, 2021
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018
Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine Medical Countermeasures July 12, 2018
Soligenix Receives Japanese Patent for Vaccine Heat Stabilization Technology Industry News May 9, 2017
Soligenix to Present at Chemical and Biological Defense S&T Conference Antimicrobial Resistance May 4, 2015
Soligenix Submits NIAID Contract Proposal for Thermostable Ricin Vaccine Health Security November 4, 2013
Motif Biosciences Unveil Novel Solutions for the Treatment Deadly Superbugs Antimicrobial Resistance September 14, 2017
Ricin Vaccine Featured at Rare Diseases and Orphan Products Summit Medical Countermeasures October 12, 2016
